Avantax Planning Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-13
Closed -$2K 1384
2018
Q3
$2K Buy
+13
New +$2.39K ﹤0.01% 1394
2018
Q2
Sell
-4,421
Closed -$744K 1731
2018
Q1
$744K Sell
4,421
-4
-0.1% -$671 0.06% 126
2017
Q4
$724K Sell
4,425
-431
-9% -$77.3K 0.07% 131
2017
Q3
$995K Buy
4,856
+490
+11% +$114K 0.08% 122
2017
Q2
$1.06M Buy
4,366
+86
+2% +$20.2K 0.09% 104
2017
Q1
$1.02M Sell
4,280
-197
-4% -$45.9K 0.09% 103
2016
Q4
$940K Buy
+4,477
New +$927K 0.1% 99

Other funds holding AGN

Avantax Planning Partners's AGN Position: Q4 2018 in Review

Avantax Planning Partners sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 13 shares — an estimated $2K sold.

Avantax Planning Partners first reported a position in AGN in Q4 2016 and held it in 7 quarters. The position peaked at $1.06M in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Avantax Planning Partners reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 13 Allergan plc shares in Q4 2018, an estimated $2K.
  • Avantax Planning Partners first reported a position in Allergan plc in Q4 2016 and held it in 7 quarters.
  • Avantax Planning Partners's Allergan plc position peaked at $1.06M in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.